Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice.
The present study has been designed to investigate the potential role of CCR-2 chemokine receptor in ischemic preconditioning as well as postconditioning induced reversal of ischemia-reperfusion injury in mouse brain. Bilateral carotid artery occlusion of 17 min followed by reperfusion for 24h was employed in present study to produce ischemia and reperfusion induced cerebral injury in mice. Cerebral infarct size was measured using triphenyltetrazolium chloride staining. Memory was evaluated using elevated plus-maze test and Morris water maze test. Rota rod test was employed to assess motor incoordination. Bilateral carotid artery occlusion followed by reperfusion produced cerebral infarction and impaired memory and motor co-ordination. Three preceding episodes of bilateral carotid artery occlusion for 1 min and reperfusion of 1 min were employed to elicit ischemic preconditioning of brain, while three episodes of bilateral carotid artery occlusion for 10s and reperfusion of 10s immediately after the completion of were employed to elicit ischemic postconditioning of brain. Both prior ischemic preconditioning as well as ischemic postconditioning immediately after global cerebral ischemia prevented markedly ischemia-reperfusion-induced cerebral injury as measured in terms of infarct size, loss of memory and motor coordination. RS 102895, a selective CCR-2 chemokine receptor antagonist, attenuated the neuroprotective effect of both the ischemic preconditioning as well as postconditioning. It is concluded that the neuroprotective effect of both ischemic preconditioning as well as ischemic postconditioning may involve the activation of CCR-2 chemokine receptors.
Chitkara College of Pharmacy, Chandigarh-Patiala National Highway, Rajpura, 140 401 Patiala, Punjab, India.
Ashish K
AK
Rehni
Thakur Gurjeet
TG
Singh
D000818:Animals; D048588:Benzoxazines / Q000494:pharmacology; D001921:Brain / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology*; D002545:Brain Ischemia / Q000150:complications / Q000503:physiopathology; D002544:Cerebral Infarction / Q000209:etiology / Q000503:physiopathology; D005260:Female; D057775:Ischemic Postconditioning; D019194:Ischemic Preconditioning; D008297:Male; D018782:Maze Learning / Q000502:physiology; D008568:Memory / Q000502:physiology; D008569:Memory Disorders / Q000209:etiology / Q000503:physiopathology; D051379:Mice; D009043:Motor Activity / Q000502:physiology; D010880:Piperidines / Q000494:pharmacology; D054390:Receptors, CCR2 / Q000037:antagonists & inhibitors / Q000502:physiology*; D015427:Reperfusion Injury / Q000209:etiology / Q000503:physiopathology
D048588:Benzoxazines; C515335:Ccr2 protein, mouse; D010880:Piperidines; C573791:RS 102895; D054390:Receptors, CCR2